San Diego, CA | November 15-19, 2024

Taconic Biosciences is going to The 75th Liver Meeting (TLM) 2024!

Taconic Biosciences is thrilled to attend The Liver Meeting, where we'll connect with professionals to share insights and explore the latest innovations in hepatology.

Are you attending this year's Liver Meeting? We'd love to meet with you! Stop by our scientific poster to learn more about the diet-conditioned NASH model or complete the form below to request a meeting to discuss your research needs. 

Featured Poster

Poster Viewing: Day 1 - P1017 

Friday, November 15, 2024 | 8:00 AM - 5:00 PM 

Automated shear wave elastography captures MASLD onset in C57BL/6NTac mice preconditioned on a modified Amylin live NASH diet

Taconic Biosciences | Revvity | Research Diets

Presented by: Laura Griffin, PhD, Field Applications Sciences, Taconic Biosciences | Tomek Czernuszewicz, PhD, Director of Ultrasound Imagine, Revvity | Steven Yeung, PhD, Director of Business Development, Research Diets Inc. | Sridhar Radhakrishnan, PhD, Senior Scientist, Research Diets Inc.   


Featured Taconic Presenter

Laura Griffin

Laura Griffin, PhD  LinkedIn

Field Applications Scientist

Dr. Laura Griffin has been working with preclinical models for a decade and is experienced in choosing appropriate models for various research applications. She obtained her PhD in Food Science and Technology at Virginia Tech, where she focused on the mechanisms by which dietary bioactive compounds influence the onset of metabolic syndrome using preclinical models. As a postdoctoral fellow at the Plants for Human Health Institute, her research shifted to focus on the impact of the gut microbiome on the metabolism of bioactive compounds. In addition to her expertise in metabolic diseases in preclinical models, Dr. Griffin is also versed in laboratory animal diets and their usage in preclinical applications.


Insight

Taconic Mouse Models Excel in Reflecting Human MASLD: A Breakthrough in Liver Disease Research

Discover how Taconic’s mouse models are revolutionizing metabolic dysfunction-associated liver disease (MASLD) research. Learn about their exceptional performance in mirroring human disease characteristics and their potential in developing new therapeutic interventions.
Support healthy liver.

Connect With an Expert